Event coordinated by the Hepatitis B Foundation

2026 International HBV Meeting

This influential international conference is being held Sept. 6-10 in Singapore.

The 2025 meeting featured:

  • Cutting-edge studies in hepatitis B (HBV) and D viruses (HDV),
  • Development of new technologies and analytical methods for understanding HBV and HDV infection,
  • Joint discussion on the latest therapeutic development with patients and clinicians,
  • Opportunities to network with the HBV/HDV community for all career stages and 
  • A platform for trainees (graduate students and post-docs) to showcase their studies.
Stay tuned for information about the 2026 program.

Registration is now open, click here for information.

 

 

Co-Organizers

Nina headshot2

Nina Le Bert, PhD
Assistant Professor, Signature Research Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore

Thomas headshot

Thomas Tu, PhD
Group Leader, Viral Hepatitis Pathogenesis, Storr Liver Centre, Westmead Institute for Medical Research, Australia

2026 Keynote Speakers

Beatty Professional 24

Julia Beatty, PhD
Chair Professor, Veterinary Medicine and Infectious Diseases, Jockey Club College of Veterinary Medicine and Life Sciences [biography]

AG PIC

Arash Grakoui, PhD
Professor of Medicine, Division of Infectious Diseases at the Emory University School of Medicine and Professor of Microbiology and Immunology, Emory University [biography]


 

2026 Distinguished Award in Hepatitis B Research recipient
20220513 tavis 003
John Tavis, PhD
Professor, Saint Louis University Director, Institute for Drug and Biotherapeutic Innovation